3 research outputs found
Differences in PO2 and PCO2 between arterial and arterialized earlobe samples
Arterialized ear lobe blood samples have been described as adequate to gauge gas exchange in acute and chronically ill patients. It is a safe procedure, usually performed by medical technicians. We have conducted a prospective study to verify the validity of this method. One hundred and fifteen consecutive adult patients were studied. Blood samples were drawn simultaneously from arterialized earlobe and radial artery. Values of partial pressure of oxygen (PO2) and of carbon dioxide (PCO2) were measured by means of blood gas electrodes. The correlation coefficients between the two samples were 0.928 for PO2 and 0.957 for PCO2 values. In spite of a highly significant correlation, the limits of agreement between the two methods were wide for PO2. Earlobe values of PO2 were usually lower than arterial values, with larger differences in the range of normal arterial PO2. On the other hand, the error and the limits of agreement were smaller for PCO2. We conclude that, in adult patients, arterialized earlobe blood PO2 is not a reliable mirror of arterial PO2
Syndrome de Muckle-Wells: description de 4 cas sur trois generations. [Muckle-Wells syndrome: 4 cases in three generations]
BACKGROUND: Muckle-Wells syndrome is a hereditary condition with variable penetrance. The main manifestations are urticarial rash, malaise in the evening, joint pain, perception deafness and renal amylosis. CASE REPORT: We describe a family with 4 affected members in 3 successive generations. Clinical expression was variable. DISCUSSION: Despite the absence of renal amylosis in our patients, this family presented the syndrome described by Muckle and Wells in 1962. As for other cases reported in the literature, the clinical course was favorable with low-dose corticosteroid therapy
St. Jude Medical valve prosthesis: an analysis of long-term outcome and prognostic factors
Between 1979 and 1984, 321 patients received 354 St. Jude Medical prostheses (194 aortic, 94 mitral, 1 tricuspid, and 32 multiple valve replacements). Follow-up was 96% complete (2967 patient-years; mean 9.5 years per patient). Actuarial event-free rates at 10 years and linearized rates (in parentheses) of late complications were as follows: embolism, 85.0% +/- 2.3% (2.3% per patient-year); anticoagulant-related hemorrhage, 74.8% +/- 2.7% (3.3% per patient-year); cerebrovascular accident, 81.8% +/- 2.5% (2.6% per patient-year); prosthesis thrombosis, 98.5% +/- 0.7% (0.1% per patient-year); endocarditis, 97.2% +/- 1.1% (0.4% per patient-year); prosthesis dysfunction, 97.1% +/- 1.0% (0.4% per patient-year); hemolytic anemia, 98.5% +/- 0.7% (0.1% per patient-year); reoperation, 97.4% +/- 1.0% (0.4% per patient-year); overall mortality, 63.3% +/- 2.7% (4.2% per patient-year); and valve-related death (including sudden death), 84.7% +/- 2.2% (1.4% per patient-year). Independent preoperative risk factors were as follows: (1) for embolism, cardiac failure as indication for operation and history of prior systemic embolism; (2) for cerebrovascular accidents, the same two factors and age; (3) for endocarditis, diabetes, chronic alcoholism, and aortic valve replacement; (4) for overall mortality, age, ejection fraction (or cardiac index or cardiothoracic index), chronic alcoholism, and history of systemic embolism; and (5) for valve-related death, chronic alcoholism, degenerative cause of valve disease, and prosthetic diameter 23 mm or smaller. Ninety percent of survivors were in New York Heart Association functional class I or II at the end of follow-up. In conclusion, this study confirms the excellent durability of the St. Jude Medical valve and the remarkable functional benefit for the majority of the patients. However, prosthesis-related complications are still common, particularly for small-diameter prostheses. Outcome is strongly related to the patient's preoperative cardiac condition and to the adequacy of anticoagulation control